Cellvizio 100 Series Systems with Confocal Miniprobes
K-Number: K171345 · 2017-08-04
Device Summary
Frequently Asked Questions
What is the Cellvizio 100 Series Systems with Confocal Miniprobes?
Cellvizio 100 Series Systems with Confocal Miniprobes is a medical device that received FDA 510(k) clearance on 2017-08-04. It is manufactured by Mauna Kea Technologies. The 510(k) number is K171345.
When was Cellvizio 100 Series Systems with Confocal Miniprobes approved by the FDA?
Cellvizio 100 Series Systems with Confocal Miniprobes received FDA 510(k) clearance on 2017-08-04, under approval number K171345.
What company makes Cellvizio 100 Series Systems with Confocal Miniprobes?
Cellvizio 100 Series Systems with Confocal Miniprobes is manufactured by Mauna Kea Technologies.
What is the FDA product code for Cellvizio 100 Series Systems with Confocal Miniprobes?
The FDA product code for Cellvizio 100 Series Systems with Confocal Miniprobes is OWN.
Related Clinical Trials
Other Devices by Mauna Kea Technologies
Related Devices (Code: OWN)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.